The GMCM Health Risk Assessment offers your doctor a fast and non-invasive way to effectively measure the state of your health in these and many other areas:
With this vital information immediately in-hand, your doctor can quickly formulate a treatment plan.
NO, not at all! Medicare covers the service and most other insurance plans. (Standard co-pays and deductibles may apply)
Yes it is! This test is completely non-invasive and can be repeated multiple times with no side effects.
Not at all! This test is completely non-invasive and can be repeated multiple times with no side effects.
The results are available immediately for the doctor to review and discuss with you.
This test is done by measuring blood pressure (BP) at the ankle and in the arm while a person is at rest using the ABI machine designed for this type of measurement. Some people also do an exercise test. In this case, the BP measurements are repeated at both sites after a few minutes of walking on a treadmill. The ABI result is used to predict the severity of peripheral artery disease (PAD). A slight drop in your ABI with exercise means that you probably have PAD. This drop may be important, because PAD can be linked to a higher risk of heart attack or stroke.
A normal resting ABI is 1.0 to 1.4. This means that your BP at your ankle is the same or greater than the pressure at your arm, and suggests that you do not have significant narrowing or blockage of blood flow.
Abnormal values for the resting ABI are 0.9 or lower and 1.40 or higher. If the ABI is 0.91 to 1.00, it is considered borderline abnormal. Abnormal values might mean you have a higher chance of having narrowed arteries in other parts of your body. This can increase your risk of a heart attack or stroke.
Problems with the ANS can range from mild to life threatening. Sometimes only one part of the nervous system is affected. In other cases, the entire ANS is affected. Some conditions are temporary and can be reversed, while others are chronic and will continue to worsen over time. Diseases such as Diabetes or Parkinson’s disease can cause irregularities with the ANS. Problems with ANS regulation often involve organ failure, or the failure of the nerves to transmit a necessary signal.
Sudomotor dysfunction testing may indicate to physicians of a patient’s peripheral nerve and cardiac sympathetic dysfunction. Neuropathy is a common complication in diabetes mellitus (DM), with 60%–70% of patients affected over lifetime. Symptoms of neuropathy are very common, and subclinical neuropathy is more common than clinical neuropathy. Neuropathy may remain undetected, and progress over time leading to serious complications. The most common associated clinical condition is peripheral neuropathy, affecting the feet. Autonomic nerve involvement is common but probably the most undiagnosed. Low scores in the sudomotor may lead a medical provider to look at clinical neuropathy.
Current evidence suggests that endothelial function is an integrative marker of the net effects of damage from traditional and emerging risk factors on the arterial wall and its intrinsic capacity for repair. Endothelial dysfunction, detected as the presence of reduced vasodilation response to endothelial stimuli, has been observed to be associated with major cardiovascular risk factors, such as aging, hyperhomocysteinemia, post menopause state, smoking, diabetes, hypercholesterolemia, and hypertension.
Insulin resistance is defined clinically as the inability of a known quantity of exogenous or endogenous insulin to increase glucose uptake and utilization in an individual as much as it does in a normal population. Insulin resistance occurs as part of a cluster of cardiovascular-metabolic abnormalities commonly referred to as "The Insulin Resistance Syndrome" or "The Metabolic Syndrome". This cluster of abnormalities may lead to the development of type 2 diabetes, accelerated atherosclerosis, hypertension or polycystic ovarian syndrome depending on the genetic background of the individual developing the insulin resistance.
The specific factors that can cause this increased risk include: obesity (particularly central), hyperglycemia, hypertension, insulin resistance and dyslipoproteinemia. When patients have one or more risk factors and are physically inactive or smoke, the cardiometabolic risk is increased even more. Medical conditions that often share the above characteristics, such as type 2 diabetes, can also increase cardiometabolic risk. The primary focus of cardiometabolic risk treatment is management of each high risk factor, including dyslipoproteinemia, hypertension, and diabetes. The management of these subjects is based principally on lifestyle measures, but various antihypertensive, lipid-lowering, insulin sensitizing, anti-obesity and antiplatelet drugs could be helpful in reducing cardiometabolic risk.
A small fiber neuropathy occurs when damage to the peripheral nerves predominantly or entirely affects the small myelinated fibers or Unmyelinated C fibers. The specific fiber types involved in this process include both small somatic and autonomic fibers. The sensory functions of these fibers include thermal perception and nociception. These fibers are involved in many autonomic and enteric functions.
High blood glucose levels over a period of years may cause a condition called autonomic neuropathy. This is damage to the nerves that control the regulation of involuntary function. When the nerve damage affects the heart, it is called cardiac autonomic neuropathy (CAN). CAN encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control, vascular dynamics and the body’s ability to adjust blood pressure. CAN is a significant cause of morbidity and mortality associated with a high risk of cardiac arrhythmias and sudden death.
The PTG CVD risk factor is the combined total of the other seven risk factors assessments. It takes into consideration the cardiovascular, as well as, the autonomic nervous system (ANS) measurements.
Using this screening’s technology gives physicians an up-to- the-minute data and analysis report for 8 essential risk factors. The report provides data useful for early diagnosis of several diseases and their complications. The sample report assists the physician and patient in formulating a program to help patients improve their health.
Medicare supports the use of electronic analytics and health records and Medicaid through the Meaningful Use Program introduced in the 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act urging participating health care providers to record and chart changes in these basic vital signs:
Screening patients with this assessment provides them with an electronic copy of their current health status, as well as a Wellness Report featuring diet and exercise suggestions, as shown on the sample report.
A. The GMCM Health Risk Assessment offers your doctor a fast and non-invasive way to effectively measure the state of your health. All you do is remove your shoes and socks, sit quietly and complete a couple of simple tasks (controlled breathing, blood pressure and standing). Areas of Health Screened:
A. NO, not at all! Medicare covers the assessment and most other insurance plans. (Standard co-pays and deductibles apply.)
A. The results are available immediately for the doctor to review and discuss with you.
DISCLAIMER: GreenMCMeds does not partake in cultivation or dispensing of cannabis in no way, shape, or form, nor are we affiliated with any dispensaries or cultivation sites.